利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

10 条记录 (耗时 0.022 秒)

    Substituted pyrazolyl urea derivatives useful in the treatment of cancer
    1.
    发明公开
    Substituted pyrazolyl urea derivatives useful in the treatment of cancer 审中-公开
    取代基吡唑基-harnstoff衍生的zur Behandlung von Krebs

    公开(公告)号：EP2295427A1

    公开(公告)日：2011-03-16

    申请号：EP10185914.8

    申请日：2005-05-02

    申请人： Bayer HealthCare, LLC

    发明人： Lee, Wendy ,  Ladouceur, Gaetan ,  Dumas, Jacques ,  Smith, Roger ,  Ying, Shihong ,  Wang, Gan ,  Chen, Zhi ,  Liu, Qingjie ,  Mokdad, Holia Hatoum

    IPC分类号： C07D401/12 ,  C07D407/12 ,  C07D413/12 ,  A61K31/535 ,  A61K31/435 ,  A61P35/00

    CPC分类号： C07D401/12 ,  C07D405/14

    摘要： The present invention relates to compounds of formula (I), pharmaceutical compositions which contain them and methods for treating cancer using compounds of formula (I).

    wherein
    R 1 and R 2 are independently:
    (a) hydrogen;
    (b) (C 1 -C 5 )alkyl, optionally substituted with one or more of hydroxy or fluoro; or
    (c) halogen;
    A is phenyl, pyridine, or pyrimidine, optionally substituted with 1 or 2 substituents that are independently (C 1 -C 5 )alkyl, (C 1 -C 5 )alkoxy, (C 1 -C 5 )haloalkyl, (C 1 -C 5 )haloalkoxy, or halogen;
    B is phenylene or naphthylene, optionally substituted with 1 to 4 substituents that are independently (C 1 -C 5 )alkyl, (C 1 -C 5 )alkoxy, (C 1 -C 5 )haloalkyl, (C 1 -C 5 )haloalkoxy, or halogen;
    L is a bridging group which is -O-, -S-, -CH 2 -.
    M is phenyl, pyridine or pyrimidine, optionally substituted.

    摘要翻译： 本发明涉及式（I）化合物，含有它们的药物组合物和使用式（I）化合物治疗癌症的方法。 其中R 1和R 2独立地为：（a）氢; （b）（C 1 -C 5）烷基，任选被一个或多个羟基或氟取代; 或（c）卤素; A是苯基，吡啶或嘧啶，任选地被1或2个独立地为（C 1 -C 5）烷基，（C 1 -C 5）烷氧基，（C 1 -C 5）卤代烷基，（C 1 -C 5） C 5）卤代烷氧基或卤素; B是亚苯基或亚萘基，任选被1至4个独立地为（C 1 -C 5）烷基，（C 1 -C 5）烷氧基，（C 1 -C 5）卤代烷基，（C 1 -C 5） 卤代烷氧基或卤素; L是-O-，-S-，-CH 2 - 的桥接基团。 M是苯基，吡啶或嘧啶，任选被取代。

    Substituted pyrazolyl urea derivatives useful in the treatment of cancer
    6.
    发明公开
    Substituted pyrazolyl urea derivatives useful in the treatment of cancer 审中-公开
    取代基吡唑基-harnstoff衍生的zur Behandlung von Krebs

    公开(公告)号：EP2295426A1

    公开(公告)日：2011-03-16

    申请号：EP10185804.1

    申请日：2005-05-02

    申请人： Bayer HealthCare, LLC

    发明人： Lee, Wendy ,  Ladouceur, Gaetan ,  Dumas, Jacques ,  Smith, Roger ,  Ying, Shihong ,  Wang, Gan ,  Chen, Zhi ,  Liu, Qingjie ,  Mokdad, Holia Hatoum

    IPC分类号： C07D401/12 ,  C07D407/12 ,  C07D413/12 ,  A61K31/535 ,  A61K31/435 ,  A61P35/00

    CPC分类号： C07D401/12 ,  C07D405/14

    摘要： The present invention relates to compounds of formula (I), pharmaceutical compositions which contain them and methods for treating cancer using compounds of formula (I).

    wherein
    R 1 and R 2 are independently:
    (a) hydrogen;
    (b) (C 1 -C 5 )alkyl, optionally substituted with one or more of hydroxy or fluoro; or
    (c) halogen;
    A is phenyl, pyridine, or pyrimidine, optionally substituted with 1 or 2 substituents that are independently (C 1 -C 5 )alkyl, (C 1 -C 5 )alkoxy, (C 1 -C 5 )haloalkyl, (C 1 -C 5 )haloalkoxy, or halogen;
    B is phenylene or naphthylene, optionally substituted with 1 to 4 substituents that are independently (C 1 -C 5 )alkyl, (C 1 -C 5 )alkoxy, (C 1 -C 5 )haloalkyl, (C 1 -C 5 )haloalkoxy, or halogen;
    L is a bridging group which is -O-, -S-, or -CH 2 -
    M is phenyl, pyridine or pyrimidine, optionally substituted.

    摘要翻译： 本发明涉及式（I）化合物，含有它们的药物组合物和使用式（I）化合物治疗癌症的方法。 其中R 1和R 2独立地为：（a）氢; （b）（C 1 -C 5）烷基，任选被一个或多个羟基或氟取代; 或（c）卤素; A是苯基，吡啶或嘧啶，任选地被1或2个独立地为（C 1 -C 5）烷基，（C 1 -C 5）烷氧基，（C 1 -C 5）卤代烷基，（C 1 -C 5） C 5）卤代烷氧基或卤素; B是亚苯基或亚萘基，任选被1至4个独立地为（C 1 -C 5）烷基，（C 1 -C 5）烷氧基，（C 1 -C 5）卤代烷基，（C 1 -C 5） 卤代烷氧基或卤素; L是-O-，-S-或-CH 2 - M是苯基，吡啶或嘧啶的任意取代的桥基。